In order to characterize which proteins of the contact phase of coagulation interact with platelets, human platelets were studied immunochemically and functionally to determine if they contain C1- inhibitor. By means of monospecific antibody to C1- inhibitor, a competitive enzyme-linked immunosorbent assay (CELISA) was developed to measure directly platelet C1- inhibitor. With the CELISA, from 33 to 115 ng of C1- inhibitor antigen per 10(8) platelets from 15 normal donors was quantified in lysates of washed human platelets solubilized in nonionic detergent. The mean concentration in 10(8) platelets was 62 +/- 33 ng (SD). Plasma C1- inhibitor either in the platelet suspension medium or on the surface of the platelets could account for only from 6.5 to 16% of the total antigen measured in the solubilized platelets. Upon functional studies, platelets contained 84 +/- 36 ng (SD) of C1- inhibitor activity in 10(8) platelets. As assessed by the CELISA, platelet C1- inhibitor antigen was immunochemically identical to plasma and purified C1- inhibitor. In contrast, the mean concentration of platelet C1- inhibitor antigen in platelets from four patients with classical hereditary angioedema was 8.3 ng/10(8) platelets (range, 5.3 to 11.3 ng/10(8) platelets). 25 and 31% of the total platelet C1- inhibitor was secreted without cell lysis from normal platelets after exposure to collagen (20 micrograms/ml) and thrombin (1 U/ml), respectively, and this secretion was blocked by metabolic inhibitors. Platelet subcellular fractionation showed that platelet C1- inhibitor resided mostly in alpha-granules, similar to the location of platelet fibrinogen. Thus, human platelets contained C1- inhibitor, which became available by platelet secretion. The identification of platelet C1- inhibitor suggests that platelets may modulate the activation of the proteins of early blood coagulation and the classical complement pathways.
A H Schmaier, P M Smith, R W Colman
Title and authors | Publication | Year |
---|---|---|
Location, location, location: Fibrin, cells, and fibrinolytic factors in thrombi
Narwal A, Whyte CS, Mutch NJ |
Frontiers in Cardiovascular Medicine | 2023 |
“Super” SERPINs—A stabilizing force against fibrinolysis in thromboinflammatory conditions
Humphreys SJ, Whyte CS, Mutch NJ |
Frontiers in Cardiovascular Medicine | 2023 |
Shedding Light on the Cell Biology of Platelet-Derived Extracellular Vesicles and Their Biomedical Applications
Chaudhary PK, Kim S, Kim S |
Life Sciences | 2023 |
Platelet and Megakaryocyte Roles in Innate and Adaptive Immunity
M Koupenova, A Livada, C Morrell |
Circulation research | 2022 |
Anticoagulant SERPINs: Endogenous Regulators of Hemostasis and Thrombosis
S Grover, N Mackman |
Frontiers in Cardiovascular Medicine | 2022 |
An Insight into Recent Advances on Platelet Function in Health and Disease
Chaudhary PK, Kim S, Kim S |
International journal of molecular sciences | 2022 |
The role of the complement system in kidney glomerular capillary thrombosis
Yoshida Y, Nishi H |
Frontiers in immunology | 2022 |
C1-inhibitor influence on platelet activation by thrombin receptors agonists.
Tarandovskiy ID, Buehler PW, Karnaukhova E |
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis | 2022 |
Interplay between platelets and coagulation
Y Sang, M Roest, B de Laat, PG de Groot, D Huskens |
Blood Reviews | 2020 |
Does Complement-Mediated Hemostatic Disturbance Occur in Traumatic Brain Injury? A Literature Review and Observational Study Protocol
A Fletcher-Sandersjöö, M Maegele, BM Bellander |
International journal of molecular sciences | 2020 |
Aspirin Effect on Staphylococcus aureus—Platelet Interactions During Infectious Endocarditis
N Hannachi, G Habib, L Camoin-Jau |
Frontiers in Medicine | 2019 |
The Human Platelet as an Innate Immune Cell: Interactions Between Activated Platelets and the Complement System
O Eriksson, C Mohlin, B Nilsson, KN Ekdahl |
Frontiers in immunology | 2019 |
Polyphosphates and Complement Activation
EM Conway |
Frontiers in Medicine | 2019 |
Complement links platelets to innate immunity
H Nording, HF Langer |
Seminars in Immunology | 2018 |
Intracellular complement activation—An alarm raising mechanism?
MP Reichhardt, S Meri |
Seminars in Immunology | 2018 |
Live-cell Imaging of Platelet Degranulation and Secretion Under Flow
AD Barendrecht, JJ Verhoef, S Pignatelli, G Pasterkamp, HF Heijnen, C Maas |
Journal of visualized experiments : JoVE | 2017 |
C1-inhibitor efficiently delays clot development in normal human whole blood and inhibits Escherichia coli-induced coagulation measured by thromboelastometry
A Landsem, H Fure, TE Mollnes, EW Nielsen, OL Brekke |
Thrombosis Research | 2016 |
Polyphosphate is a novel cofactor for regulation of complement by a serpin, C1 inhibitor
LC Wijeyewickrema, E Lameignere, L Hor, RC Duncan, T Shiba, RJ Travers, PR Kapopara, V Lei, SA Smith, H Kim, JH Morrissey, RN Pike, EM Conway |
Blood | 2016 |
The complement system: an evolution in progress
B Ghebrehiwet |
F1000Research | 2016 |
Platelets and Infections – Complex Interactions with Bacteria
H Hamzeh-Cognasse, P Damien, A Chabert, B Pozzetto, F Cognasse, O Garraud |
Frontiers in immunology | 2015 |
Platelet Surface-Associated Activation and Secretion-Mediated Inhibition of Coagulation Factor XII
NV Zakharova, EO Artemenko, NA Podoplelova, AN Sveshnikova, IA Demina, FI Ataullakhanov, MA Panteleev, Z Li |
PloS one | 2015 |
Complement and platelets: Mutual interference in the immune network
C Speth, G Rambach, R Würzner, C Lass-Flörl, H Kozarcanin, OA Hamad, B Nilsson, KN Ekdahl |
Molecular Immunology | 2015 |
Targeting the host hemostatic system function in bacterial infection for antimicrobial therapies
Y Xu, H Yu, H Sun |
Journal of Thrombosis and Thrombolysis | 2013 |
Methods in Enzymology
JD Stone, AS Chervin, DH Aggen, DM Kranz |
Protein Engineering for Therapeutics Part B | 2012 |
Platelet α-granules: Basic biology and clinical correlates
P Blair, R Flaumenhaft |
Blood Reviews | 2009 |
Amidine surface modification of poly(acrylonitrile-co-vinyl chloride) reduces platelet adhesion
EK Yim, MV Sefton |
Journal of Biomedical Materials Research Part A | 2009 |
Sepsis
JM O’Brien, NA Ali, SK Aberegg, E Abraham |
The American Journal of Medicine | 2007 |
C1 Inhibitor Infusion Modifies Platelet Activity in Hereditary Angioedema Patients
L Coppola, S Guastafierro, G Verrazzo, A Coppola, DD Lucia, A Tirelli |
Archives of pathology & laboratory medicine | 2002 |
Platelets
JN George |
The Lancet | 2000 |
The Complement FactsBook
LB Klickstein, JM Moulds |
The Complement FactsBook | 2000 |
Handbook of Platelet Physiology and Pharmacology
GH Rao |
1999 | |
C1q and Systemic Lupus Erythematosus
MJ Walport, KA Davies, M Botto |
Immunobiology | 1998 |
High Molecular Weight Kininogen Regulates Prekallikrein Assembly and Activation on Endothelial Cells: A Novel Mechanism for Contact Activation
G Motta, R Rojkjaer, AA Hasan, DB Cines, AH Schmaier |
Blood | 1998 |
Platelets and Their Factors
F von Bruchhausen, U Walter |
1997 | |
Coagulation Factor Activation in Stored Platelet Concentrates is Modulated by the Platelets
MI Gyöngyössy-Issa, T Black, DV Devine |
Vox Sanguinis | 1996 |
Platelet α-granules
P Harrison, EM Cramer |
Blood Reviews | 1993 |
Complement in Health and Disease
K Whaley, M Loos, JM Weiler |
1993 | |
Membrane Defenses Against Attack by Complement and Perforins
CJ Parker |
1992 | |
Domain 3 of kininogens contains a cell-binding site and a site that modifies thrombin activation of platelets
YP Jiang, W Muller-Esterl, AH Schmaier |
The Journal of biological chemistry | 1992 |
THE ORIGIN AND PHYSIOLOGICAL RELEVANCE OF α-GRANULE ADHESIVE PROTEINS
P Harrison, GF Savidge, EM Cramer |
British Journal of Haematology | 1990 |
Characteristics of a thrombin inhibitor secreted by activated platelets
JJ Miller, TC Detwiler |
Archives of Biochemistry and Biophysics | 1990 |
Protease Nexin-II(amyloid β-protein Precursor): a Platelet α-Granule Protein
WE Nostrand, AH Schmaier, JS Farrow, DD Cunningham |
Science | 1990 |
F XII
G Fuhrer, MJ Gallimore, W Heller, |
Blut Zeitschrift für die Gesamte Blutforschung | 1990 |
Secretion of the terminal complement proteins, C5–C9, by human platelets
JJ Houle, JP Leddy, SI Rosenfeld |
Clinical Immunology and Immunopathology | 1989 |
Synthesis and expression of C1 inhibitor by human umbilical vein endothelial cells
AH Schmaier, SC Murray, GD Heda, A Farber, A Kuo, K McCrae, DB Cines |
The Journal of biological chemistry | 1989 |
Interaction of type 1 plasminogen activator inhibitor with the enzymes of the contact activation system
M Berrettini, RR Schleef, F España, DJ Loskutoff, JH Griffin |
The Journal of biological chemistry | 1989 |
Interactions of the platelets in paroxysmal nocturnal hemoglobinuria with complement. Relationship to defects in the regulation of complement and to platelet survival in vivo
DV Devine, RS Siegel, WF Rosse |
Journal of Clinical Investigation | 1987 |
Regulation of the activity of platelet-bound C3 convertase of the alternative pathway of complement by platelet factor H
DV Devine, WF Rosse |
Proceedings of the National Academy of Sciences | 1987 |
Effect of negatively charged activating compounds on inactivation of factor XIIa by Cl̄ inhibitor
RA Pixley, A Schmaier, RW Colman |
Archives of Biochemistry and Biophysics | 1987 |
Isolation and characterization of an inhibitor of factor XIIa from bovine plasma
RD Thornton, EP Kirby |
The Journal of biological chemistry | 1987 |
High molecular weight kininogen is an inhibitor of platelet calpain
AH Schmaier, H Bradford, LD Silver, A Farber, CF Scott, D Schutsky, RW Colman |
Journal of Clinical Investigation | 1986 |
The contact activation system: Biochemistry and interactions of these surface-mediated defense reactions
RW Colman, AH Schmaier, OD Ratnoff |
Critical Reviews in Oncology/Hematology | 1986 |
Functional C8 associated with human platelets
F Tedesco, P Densen, MA Villa, G Presani, L Roncelli, VE di san Secondo |
Clinical & Experimental Immunology | 1986 |